Latest abstracts in Otolaryngology

1. Delivery techniques for allergy immunotherapy have evolved over the last century from primarily subcutaneous immunotherapy to a current mixture of sublingual and subcutaneous immunotherapy. Allergic rhinitis and allergic asthma patients selected as appropriate candidates for allergy immunotherapy have options including subcutaneous shots, sublingual drops, or sublingual tablets.
2. Tinnitus is hypothesized to be an auditory phantom phenomenon resulting from spontaneous neuronal activity somewhere along the auditory pathway. The neural abnormalities underlying tinnitus are largely unknown. In this study, authors evaluated the functional characteristics and the auditory system synchronization using Auditory Brainstem Response (ABR) in normal hearing tinnitus patients.
3. Allergen immunotherapy (AIT) is the only treatment that has modified the natural history of allergic diseases. However, since its overall effect on the immune system has not been elucidated, AIT is either absolutely or relatively contraindicated in patients with rheumatic autoimmune diseases (RADs). Hence, a single-center retrospective observational study was conducted and it was found that AIT is a safe and effective treatment modality for patients with allergic rhinitis complicated by RADs.
4. In terms of audiological advantage, extended ear hearing aids are similar to RITE and CIC as demonstrated from the Matrix speech reception threshold. The result was confirmed using the APHAB questionnaire. Extended wear devices are better than daily hearing aids concerning the “personal image”.

Click here to read the full article